Literature DB >> 3308215

Role of the pineal gland in immunity: II. Melatonin enhances the antibody response via an opiatergic mechanism.

G J Maestroni1, A Conti, W Pierpaoli.   

Abstract

The pineal gland constitutes a major neuroendocrine organ in the brain. It transduces exogenous signals such as circadian and seasonal variations of light and temperature into proper hormonal changes which adjust and adapt internal endocrine functions. These pineal activities seem to be exerted via circadian synthesis and release of the indoleamine melatonin, a neurohormone secreted by the pineal itself. Alteration of circadian rhythms have been associated with affective disorders, psychosomatic diseases, cancer and many other pathologies. We have reported that functional and pharmacologic inhibition of melatonin synthesis results in depressed immune functions in vivo and that exogenous, evening administration of melatonin enhances antibody formation via an antigen-activated process and also antagonizes the immunosuppressive effects of corticosterone. We communicate here findings demonstrating that (a) three different inbred strains of mice possess a clear-cut cycle of melatonin levels in serum, (b) that melatonin administered in the evening enhances primary antibody response (IgM and IgG immunoglobulins) in vivo according to a dose-response behaviour and that (c) the opioid receptors blocker naltrexone antagonizes the immunostimulatory effect of melatonin. These findings point to a fundamental immunoregulatory role of circadian melatonin and to an activity of the neurohormone via opioid peptides.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3308215      PMCID: PMC1542725     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Pharmacological control of the hormonally modulated immune response. II. Blockade of antibody production by a combination of drugs acting on neuroendocrine functions. Its prevention by gonadotropins and corticotrophin.

Authors:  W Pierpaoli; G J Maestroni
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

2.  Pharmacologic control of the hormonally modulated immune response. III. Prolongation of allogeneic skin graft rejection and prevention of runt disease by a combination of drugs acting on neuroendocrine functions.

Authors:  W Pierpaoli; G J Maestroni
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

3.  Beta-endorphin modulates immune functions. A review.

Authors:  E G Fischer; N E Falke
Journal:  Psychother Psychosom       Date:  1984       Impact factor: 17.659

Review 4.  The immune system as a sensory organ.

Authors:  J E Blalock
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

5.  Differences in the inhibitory effects of normorphine and opioid peptides on the responses of the vasa deferentia of two strains of mice.

Authors:  A A Waterfield; J A Lord; J Hughes; H W Kosterlitz
Journal:  Eur J Pharmacol       Date:  1978-01-15       Impact factor: 4.432

6.  Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins.

Authors:  E M Smith; A C Morrill; W J Meyer; J E Blalock
Journal:  Nature       Date:  1986 Jun 26-Jul 2       Impact factor: 49.962

7.  Effect of naloxone on the nocturnal rise of rat pineal melatonin content.

Authors:  P R Lowenstein; E N Pereyra; C González Solveyra; D P Cardinali
Journal:  Eur J Pharmacol       Date:  1984-02-17       Impact factor: 4.432

8.  Genetic control of melatonin synthesis in the pineal gland of the mouse.

Authors:  S Ebihara; T Marks; D J Hudson; M Menaker
Journal:  Science       Date:  1986-01-31       Impact factor: 47.728

9.  Supersensitivity and subsensitivity of the beta-adrenergic receptor in pineal gland regulated by catecholamine transmitter.

Authors:  T Deguchi; J Axelrod
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

10.  Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone.

Authors:  G J Maestroni; A Conti; W Pierpaoli
Journal:  J Neuroimmunol       Date:  1986-11       Impact factor: 3.478

View more
  27 in total

Review 1.  A review of the multiple actions of melatonin on the immune system.

Authors:  Antonio Carrillo-Vico; Juan M Guerrero; Patricia J Lardone; Russel J Reiter
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

2.  Different effects of melatonin on experimental granulomatous inflammation.

Authors:  Nadir Ernesto de la Rocha; Alejandra Ester Rotelli; Teresita Guardia; Lilian Eugenia Pelzer
Journal:  Inflammation       Date:  2004-08       Impact factor: 4.092

Review 3.  A risk-benefit assessment of naltrexone in the treatment of alcohol dependence.

Authors:  B J Berg; H M Pettinati; J R Volpicelli
Journal:  Drug Saf       Date:  1996-10       Impact factor: 5.606

4.  Seasonal pattern of melatonin excretion in humans: relationship to daylength variation rate and geomagnetic field fluctuations.

Authors:  T J Paparrigopoulos; C N Stefanis
Journal:  Experientia       Date:  1996-03-15

5.  Role of the pineal gland in immunity. III. Melatonin antagonizes the immunosuppressive effect of acute stress via an opiatergic mechanism.

Authors:  G J Maestroni; A Conti; W Pierpaoli
Journal:  Immunology       Date:  1988-03       Impact factor: 7.397

6.  Regulatory effect of melatonin on cytokine disturbances in the pristane-induced lupus mice.

Authors:  Ling-Ling Zhou; Wei Wei; Jun-Feng Si; Dong-Ping Yuan
Journal:  Mediators Inflamm       Date:  2010-07-20       Impact factor: 4.711

7.  Continuous darkness and continuous light induce structural changes in the rat thymus.

Authors:  I Mahmoud; S S Salman; A al-Khateeb
Journal:  J Anat       Date:  1994-08       Impact factor: 2.610

8.  Melatonin biosynthesis and metabolism in peripheral blood mononuclear leucocytes.

Authors:  L M Finocchiaro; V E Nahmod; J M Launay
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

9.  Protective effects of melatonin in mice infected with encephalitis viruses.

Authors:  D Ben-Nathan; G J Maestroni; S Lustig; A Conti
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

Review 10.  Clinical aspects of the melatonin action: impact of development, aging, and puberty, involvement of melatonin in psychiatric disease and importance of neuroimmunoendocrine interactions.

Authors:  F Waldhauser; B Ehrhart; E Förster
Journal:  Experientia       Date:  1993-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.